Free Trial

Cyclacel Pharmaceuticals (CYCC) SEC Filings & 10K Form

Cyclacel Pharmaceuticals logo
$1.46 -0.11 (-7.01%)
Closing price 04:00 PM Eastern
Extended Trading
$1.53 +0.07 (+4.79%)
As of 07:15 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Cyclacel Pharmaceuticals SEC Filings

DateFilerForm TypeView
05/15/2025
2:24 PM
ARMISTICE CAPITAL, LLC (Filed by)
Cyclacel Pharmaceuticals (Subject)
Cyclacel Pharmaceuticals, Inc. (Subject)
Form SCHEDULE 13G/A
05/15/2025
1:39 PM
Cyclacel Pharmaceuticals (Issuer)
Cyclacel Pharmaceuticals, Inc. (Issuer)
Ho Jien Shiung (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/14/2025
2:30 PM
Cyclacel Pharmaceuticals (Issuer)
Cyclacel Pharmaceuticals, Inc. (Issuer)
Tan Kok Hui (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/14/2025
7:50 AM
Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
Form PRE 14C
05/07/2025
10:00 AM
Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2025
11:15 PM
Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
Form EFFECT
04/25/2025
1:38 PM
Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
Form S-1
Registration statement under Securities Act of 1933  
04/24/2025
2:09 PM
Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
Form DEF 14A
04/21/2025
5:08 AM
Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/17/2025
4:00 PM
Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
04/02/2025
3:42 PM
Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/31/2025
2:31 PM
Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
Form NT 10-K
03/25/2025
1:19 PM
Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
Form D
Notice of Exempt Offering of Securities 
03/24/2025
10:03 AM
Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/24/2025
5:01 AM
Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
Form PRE 14C
03/14/2025
5:00 AM
Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2025
9:32 AM
Cyclacel Pharmaceuticals (Subject)
Cyclacel Pharmaceuticals, Inc. (Subject)
Doris Wong Sing Ee (Filed by)
Form SCHEDULE 13D
02/28/2025
3:46 PM
Cyclacel Pharmaceuticals (Subject)
Cyclacel Pharmaceuticals, Inc. (Subject)
Lazar David E. (Filed by)
Form SCHEDULE 13D
02/28/2025
3:47 PM
Ben-Tzvi Avraham (Reporting)
Cyclacel Pharmaceuticals (Issuer)
Cyclacel Pharmaceuticals, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2025
3:48 PM
Cyclacel Pharmaceuticals (Issuer)
Cyclacel Pharmaceuticals, Inc. (Issuer)
Lazar David E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2025
3:48 PM
Cyclacel Pharmaceuticals (Issuer)
Cyclacel Pharmaceuticals, Inc. (Issuer)
NATAN DAVID (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2025
10:31 AM
Cyclacel Pharmaceuticals (Issuer)
Cyclacel Pharmaceuticals, Inc. (Issuer)
Kiu Cu Seng (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/28/2025
10:31 AM
Chong Kwang Fock (Reporting)
Cyclacel Pharmaceuticals (Issuer)
Cyclacel Pharmaceuticals, Inc. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/28/2025
10:32 AM
Cyclacel Pharmaceuticals (Issuer)
Cyclacel Pharmaceuticals, Inc. (Issuer)
Doris Wong Sing Ee (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/24/2025
7:31 AM
Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
4:40 PM
ARMISTICE CAPITAL, LLC (Filed by)
Cyclacel Pharmaceuticals (Subject)
Cyclacel Pharmaceuticals, Inc. (Subject)
Form SCHEDULE 13G/A
02/10/2025
4:45 PM
Cyclacel Pharmaceuticals (Issuer)
Cyclacel Pharmaceuticals, Inc. (Issuer)
Lazar David E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2025
3:46 PM
Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/05/2025
3:40 PM
Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/21/2025
5:02 AM
Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
Form DEF 14A
01/10/2025
3:46 PM
Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
Form PRER14A
01/10/2025
5:04 AM
Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2025
4:25 PM
Ben-Tzvi Avraham (Reporting)
Cyclacel Pharmaceuticals (Issuer)
Cyclacel Pharmaceuticals, Inc. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/08/2025
5:30 AM
Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
Form PRE 14A
01/07/2025
6:04 PM
Cyclacel Pharmaceuticals (Issuer)
Cyclacel Pharmaceuticals, Inc. (Issuer)
Lazar David E. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/07/2025
6:06 PM
Cyclacel Pharmaceuticals (Issuer)
Cyclacel Pharmaceuticals, Inc. (Issuer)
NATAN DAVID (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/07/2025
6:07 PM
Cyclacel Pharmaceuticals (Issuer)
Cyclacel Pharmaceuticals, Inc. (Issuer)
NATAN DAVID (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
7:17 AM
Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/12/2024
3:15 PM
Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/26/2024
5:38 AM
Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
Form D
Notice of Exempt Offering of Securities 
11/15/2024
5:05 AM
Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Trump’s Exec Order #14154 could be a “Millionaire-Maker” (Ad)

Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans a chance at true financial independence in the months ahead.” We recently sat down with Rickards to capture all the key details on tape.

For the moment, you can watch this interview free of charge – just click here.
11/14/2024
6:21 PM
Cyclacel Pharmaceuticals (Subject)
Cyclacel Pharmaceuticals, Inc. (Subject)
Lind Global Fund II LP (Filed by)
Form SC 13G/A
11/12/2024
4:10 PM
Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/12/2024
4:00 PM
Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2024
8:00 AM
Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
Form RW
10/24/2024
3:00 PM
Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/09/2024
5:00 AM
Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
Form S-1
Registration statement under Securities Act of 1933  
08/30/2024
8:08 AM
Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/22/2024
3:15 PM
Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/31/2024
3:00 PM
Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/24/2024
8:34 PM
Cyclacel Pharmaceuticals (Filer)
Cyclacel Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:CYCC) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners